The drug developed by the pharmaceutical company Hetero has been approved by the Drug Controller General of India.
Biosimilar Version of Remicade for Autoimmune Diseases Likely to Get FDA Approval
Remsima could soon become the second biosimilar drug next to Zarzio to be approved by the U.S. Food and Drug Administration.
Remsima could soon become the second biosimilar drug next to Zarzio to be approved by the U.S. Food and Drug Administration.
‘Hyderabad-based pharmaceutical company Hetero Drugs has launched its biosimilar 'Bevacizumab' for the treatment of metastatic colorectal cancer in India.
’
The product will be available in a single dose vial with two strengths, 100 and 400mg. Hetero will manufacture the drugs in the facility based in Hyderabad. Dr BPS Reddy, CMD, Hetero Group of Companies said: “It has been an exciting journey for us in Biologics. Hetero’s Bevacizumab is the third product in our biologics portfolio, after Darbepoetin alfa and Rituximab. We believe CizumabTM will be a cost-effective treatment option to patients in India.”
Source-Medindia
Hyderabad-Based Pharmaceutical Company Launches Biosimilar Rituximab in India
Rituximab is used alone or with other drugs to treat non-Hodgkin's lymphoma, chronic lymphocytic leukaemia and rheumatoid arthritis.
Rituximab is used alone or with other drugs to treat non-Hodgkin's lymphoma, chronic lymphocytic leukaemia and rheumatoid arthritis.
Mylan Launches World�s First Trastuzumab Biosimilar in India
American drug pharmaceutical firm Mylan announced the launch of its breast cancer drug through its Indian subsidiary in the country.
American drug pharmaceutical firm Mylan announced the launch of its breast cancer drug through its Indian subsidiary in the country.
First Biosimilar Launched by Cipla for Rheumatic Disorders
Mumbai-based pharmaceutical company Cipla revealed that it has launched etanercept biosimilar drug in India to treat rheumatic disorders.
Mumbai-based pharmaceutical company Cipla revealed that it has launched etanercept biosimilar drug in India to treat rheumatic disorders.
